Truvada is also recommended by the Centers for Disease Control and Prevention as pre-exposure prophylaxis (PrEP) for HIV-negative people at risk of contracting HIV.
Truvada made with tenofovir disiproxil fumarate which is sold separately or Viread generic and other is emtricitabine which is sold separately from Emtriva. Both drugs belong to a class of drugs called reverse transcriptase nucleoside / nucleotide inhibitors against HIV.
Truvada was approved for the treatment of HIV in August 2004 by the U.S. Food and Drug Administration and for use as a PrEP for HIV prevention in July 2012.
As HIV treatment Truvada should be used in combination with other anti-HIV drugs.
Like PrEP, Truvada should be used in conjunction with therapy for risk reduction, effective and consistent use of contraceptives, routine HIV testing and screening, and treatment of other transmitted infections.
Before taking this drug tell your doctor if you have kidney disease. Additionally, talk to your doctor if you're pregnant or are trying to become pregnant; if you're breastfeeding and all of your medical conditions, including all of your prescription and counter drugs and supplements.